Similar articles

• Peg-interferon plus nucleotide analogue in patients with chronic hepatitis B with low viral load - Authors' reply.

  Jansen L, Stelma F, Niet A, Reesink HW. Jansen L, et al. Lancet Gastroenterol Hepatol. 2017 Sep;2(9):629. doi: 10.1016/S2468-1253(17)30221-2. Lancet Gastroenterol Hepatol. 2017. PMID: 28786385 No abstract available.
• Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial.

  de Niet A, Jansen L, Stelma F, Willemse SB, Kuiken SD, Weijer S, van Nieuwkerk CMJ, Zaaijer HL, Molenkamp R, Takkenberg RB, Koot M, Verheij J, Beuers U, Reesink HW. de Niet A, et al. Lancet Gastroenterol Hepatol. 2017 Aug;2(8):576-584. doi: 10.1016/S2468-1253(17)30083-3. Epub 2017 May 15. Lancet Gastroenterol Hepatol. 2017. PMID: 28522204 Clinical Trial.
• [Efficacy of pegylated-interferon alpha-2a treatment in patients with HBeAg-positive chronic hepatitis B and partial viral response to nucleoside analogue therapy].

  Li MH, Hu LP, Zhang L, Lu Y, Shen G, Wu SL, Chang M, Mu CQ, Wu YZ, Yang M, Song SJ, Zhang SF, Hua WH, Xie Y, Cheng J, Xu DZ. Li MH, et al. Zhonghua Gan Zang Bing Za Zhi. 2015 Nov;23(11):826-31. doi: 10.3760/cma.j.issn.1007-3418.2015.11.006. Zhonghua Gan Zang Bing Za Zhi. 2015. PMID: 26743242 Chinese.
• Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?

  Lampertico P, Viganò M, Colombo M. Lampertico P, et al. Liver Int. 2013 Feb;33 Suppl 1:157-63. doi: 10.1111/liv.12064. Liver Int. 2013. PMID: 23286860 Review.
• Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.

  Dusheiko G. Dusheiko G. Liver Int. 2013 Feb;33 Suppl 1:137-50. doi: 10.1111/liv.12078. Liver Int. 2013. PMID: 23286858 Review.